These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6705799)

  • 21. Modification of the reactivity of three amino-acid residues in elongation factor 2 during its binding to ribosomes and translocation.
    Lavergne JP; Marzouki A; Reboud AM; Reboud JP
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):231-7. PubMed ID: 2322578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
    Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
    Montanaro L; Sperti S; Testoni G; Mattioli A
    Biochem J; 1976 Apr; 156(1):15-23. PubMed ID: 182140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of guanosine triphosphate analogues with elongation factor G of Escherichia coli.
    Hamel E
    Eur J Biochem; 1976 Apr; 63(2):431-40. PubMed ID: 770173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function of sulfhydryl groups in ribosome-elongation factor G reactions. Assignment of guanine nucleotide binding site to elongation factor G.
    Marsh RC; Chinali G; Parmeggiani A
    J Biol Chem; 1975 Nov; 250(21):8344-52. PubMed ID: 172495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding of tritiated elongation factors 1 and 2 to ribosomes from Krebs II mouse ascites tumor cells.
    Nolan RD; Grasmuk H; Drews J
    Eur J Biochem; 1975 Jan; 50(2):391-402. PubMed ID: 1126342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of guanosine nucleotides with elongation factor 2. I. Equilibrium dialysis studies.
    Henriksen O; Robinson EA; Maxwell ES
    J Biol Chem; 1975 Jan; 250(2):720-4. PubMed ID: 1112784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of the accessibility of ribosomal proteins after elongation factor 2 binding to rat liver ribosomes and during translocation.
    Marzouki A; Lavergne JP; Reboud JP; Reboud AM
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):238-44. PubMed ID: 2322579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
    Nurten R; Albeniz I; Bermek E
    IUBMB Life; 1999 Nov; 48(5):557-62. PubMed ID: 10637774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of elongation factor EF-Tu with gamma-amides of GTP and beta-amides of GDP bearing the azidoaryl group or the chloroethylaminoaryl group placed at the terminal phosphate.
    Babkina GT; Jonák J; Rychlík I
    Biochim Biophys Acta; 1982 Aug; 698(2):116-27. PubMed ID: 6751396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the elongation factors from calf brain. 2. Functional properties of EF-1 alpha, the action of physiological ligands and kirromycin.
    Crechet JB; Parmeggiani A
    Eur J Biochem; 1986 Dec; 161(3):647-53. PubMed ID: 3641717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of elongation factor 2 with ribosomes from silk gland. Formation of an EF-2-ribosome-GDP complex.
    Taira H; Ejiri S; Shimura K
    J Biochem; 1974 Nov; 76(5):949-57. PubMed ID: 4616032
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the polypeptide elongation factor 2 from Sulfolobus solfataricus. Interaction with guanosine nucleotides and GTPase activity stimulated by ribosomes.
    Raimo G; Masullo M; Bocchini V
    J Biol Chem; 1995 Sep; 270(36):21082-5. PubMed ID: 7673137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
    Jacquet E; Parmeggiani A
    Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of reticulocyte elongation factor 1 to ribosomes and nucleic acids.
    Kolb AJ; Redfield B; Twardowski T; Weissbach H
    Biochim Biophys Acta; 1978 Jul; 519(2):398-405. PubMed ID: 248283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O; Nilsson L
    J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the elongation factors from calf brain. 3. Properties of the GTPase activity of EF-1 alpha and mode of action of kirromycin.
    Crechet JB; Parmeggiani A
    Eur J Biochem; 1986 Dec; 161(3):655-60. PubMed ID: 3024979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guanine-nucleotide exchange on ribosome-bound elongation factor G initiates the translocation of tRNAs.
    Zavialov AV; Hauryliuk VV; Ehrenberg M
    J Biol; 2005; 4(2):9. PubMed ID: 15985150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of an inhibitor of ribosome-dependent GTP hydrolysis by elongation factor G.
    Voigt J; Nagel K
    Eur J Biochem; 1990 Dec; 194(2):579-85. PubMed ID: 2269283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.